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ABSTRACT 
 
A Family-Based Association Study of Conduct Disorder 
by 
Xueqiu Jian 
 
Conduct disorder is a psychiatric syndrome in childhood and adolescence that is one of the 
most common childhood disorders with continuously increasing prevalence but uncertain 
pathogenesis. We performed a genome-wide, family-based association study of CD using 
P2BAT/FBAT software. The data were gathered from Collaborative Study on the Genetics of 
Alcoholism (COGA) and International Multi-Center ADHD Genetics Project (IMAGE).  
 
Using COGA data, we identified 20 markers that showed suggestive associations (p<10-3) with 
CD. Nine of them are located in known genes. Two genes, ADAM10 and CAMK2A, which had 
been reported associated with Alzheimer's disease (AD), bipolar disorder, and depression, were 
of more concern. Using IMAGE sample, our results were well replicated. 
 
This study identified several CD associated genetic variants, especially 2 novel candidate 
genes. These findings may serve as a resource for replication in other populations to elucidate 
the potential role of these genetic variants in CD. 
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CHAPTER 1 
INTRODUCTION 
 
Conduct disorder (CD) is a psychiatric syndrome occurring in childhood and adolescence 
and is characterized by a longstanding pattern of violations of rules and antisocial behavior 
(Searight, Rottnek, & Abby, 2001). Symptoms typically include aggression, frequent lying, 
running away from home overnight, and destruction of property (American Psychiatric 
Association [APA], 1994). CD is one of the most prevalent childhood disorders that affects 
1.5%-3.4% of adolescents (Steiner, 1997) and is more common in males than in females (APA, 
1994). Not only does CD associate with social malfunctioning, individuals with CD also show 
a high comorbidity with attention-deficit/hyperactivity disorder (ADHD) (Biederman, 
Newcorn, & Sprich, 1991), which is characterized by frequent and severe inattention, 
distractibility, impulsivity, or hyperactivity (Biederman & Faraone, 2005). Moreover, CD has 
been proved a robust predictor of both concurrent and future alcohol dependence (Deas & 
Brown, 2006). The fact that patients with CD may face so many problems leads to the necessity 
to better understand the pathogenesis of the disease. 
Generally, the perception of human diseases can be divided into two levels: individual level 
and population level. In our field of study, we are not interested in the nosogenesis of CD or its 
pathophysiological process in certain individuals. Rather, the focus of epidemiologic field is 
whether the disease has a genetic disposition and if so, the extent to which CD is determined by 
genetic factors in a population. Twin studies have confirmed that genetic factors play a 
significant role in CD (Dick et al., 2002; Goldstein, Prescott, & Kendler, 2001; Slutske et al., 
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1997), but the location is not clear. Based on this, our study aims to identify novel single 
nucleotide polymorphisms (SNPs) associated with CD and related known genes. Definitions of 
several terms are listed in Appendix A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12 
 
CHAPTER 2 
LITERATURE REVIEW 
 
Genetic Components of Conduct Disorder 
A substantial body of epidemiologic evidence indicates that CD has a significant genetic 
disposition. Twin studies take advantage of the fact that monozygotic (MZ) twins share 100% 
of their genes, whereas dizygotic (DZ) twins, who are like ordinary sibling pairs genetically, 
share 50% of their genes identical by descent. Therefore, MZ twins should be more similar than 
DZ twins on a trait or disorder influenced by genes. Twin studies examine the extent to which 
observed individual differences are due to differences in genetic, shared environmental, or 
nonshared environmental influences. Heritability (h2) is the proportion of observed differences 
that can be explained by genetic differences. In the Australian Twin Study, more than 70% of 
the variance in conduct disorder was attributable to genetic factors (Slutske et al., 1997). Other 
twin and family studies showed CD with modest heritability (about 40%) (Dick et al., 2002; 
Dick et al., 2004; Goldstein et al., 2001; Hicks, Krueger, Iacono, McGue, & Patrick, 2004; 
Rhee & Waldman, 2002; Subbarao et al., 2008; True et al., 1999).  
 
Genome-Wide Linkage Studies 
Two major approaches have been used to map genetic variants that influence disease risk: 
linkage analysis and association studies. These can be deployed by using the genome-wide or 
the candidate gene method. Until recently genome-wide scans were done by linkage only, 
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whereas association studies usually aimed at candidate genes. This is no longer true, as new 
genome-wide association (GWA) studies have already proven their usefulness. 
Genome-wide linkage analysis involves genotyping of hundreds of polymorphic markers 
spread uniformly across the whole genome in families with multiple affected relatives (or 
multiple relatives in whom a trait has been measured). Markers that segregate with the disease 
(or trait) in relatives more often than expected are used to narrow down the location of the 
disease gene. The analysis is based upon a logarithmic odds ratio (LOD score) that expresses 
the likelihood of linkage divided by the likelihood of nonlinkage (Lander & Schork, 1994). 
The first genome-wide linkage screen for genes influencing CD was conducted by Dick et 
al. (2004), which suggested regions on chromosomes 19 (with a maximum LOD score of 2.8 
near marker D19S714) and 2 (with a maximum LOD score of 2.4 near marker D2S1331) may 
contain genes conferring risk to CD. Other candidate regions were also reported (on 
chromosomes 12 and 3 for CD diagnosis, and chromosomes 1 and 19 for CD symptoms) but 
have weaker evidence for linkage. Divergently, another genome-wide linkage analysis by 
Stallings et al. (2005) provided evidence of linkage for CD symptoms to regions on 
chromosomes 9q34 (near markers D9S1826 and D9S1838) and 17q12 (near marker D17S798). 
Later, Kendler et al. (2006) reported regions on chromosomes 1q (with a maximal LOD score 
of 3.16 near marker D1S196) and 14p (with a maximal LOD score of 2.36 near marker 
D14S261) have the strongest evidence for linkage to CD, followed by regions on chromosomes 
2, 7, 8, and 10 with weaker evidence, which moderately provided some support for the findings 
by Dick et al. (2004). 
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Candidate Gene Association Studies 
While linkage studies have a demonstrated utility in mapping rare, highly penetrant 
disease genes, results in mapping more moderate loci have been disappointing. The 
opportunities for mapping low penetrance disease predisposing genes with families alone are 
diminishing. Risch and Merikangas (1996) argued that case-control association studies present 
much greater power to detect the locus specific relative risks underlying polygenic disease. 
Association studies compare the allele frequency of a polymorphic marker, or a set of 
markers, in unrelated patients (cases) and healthy controls to identify markers that differ 
significantly between the two groups. These studies have much greater power to detect the 
effects of common variants (Risch & Merikangas, 1996).  
There are several advantages of association studies compared to linkage studies. First, 
association studies have increased precision in localizing a disease susceptibility locus. Second, 
association studies may have increased power compared to linkage studies, particularly for 
genes with small individual effects (Risch & Merikangas, 1996); this is because the excess 
sharing of a particular allele over that expected by chance among families (association) is 
greater than the excess sharing over that expected by chance within families (linkage). 
Moreover, linkage analysis, traditionally the most reliable of genetic methods when applied to 
Mendelian traits, has proven to be a much less reliable tool for the study of non-Mendelian 
diseases with a disappointingly high false-positive rate (Lake, Blacker, & Laird, 2000; Risch, 
2000). 
Several candidate genes have been tested for their association with CD. GABRA2, a gene 
that has previously been associated with adult AD, was reported significantly associated with 
15 
 
childhood CD symptoms by Dick et al. (2006). But their findings were not supported by a very 
recent study conducted by Sakai et al. (2010), although they did demonstrate a significant 
case-control association between a SNP in GABRA2 (rs279871) and CD. Two studies 
suggested a strong association between CD and 5HTTLPR, a functional polymorphism in the 
promoter region of the serotonin transporter gene (SLC6A4) (Malmberg, Wargelius, 
Lichtenstein, Oreland, & Larsson, 2008; Sakai et al., 2006). Inconsistently, in another study 
using a larger sample from a general population, Sakai et al. (2007) did not find a significant 
association between 5HTTLPR and conduct problems. In fact, Cadoret et al. (2003) failed to 
detect a main effect between 5HTTLPR status and CD, although there was some evidence that 
5HTTLPR variants play a significant role in CD when interacted with other genetic risk factors. 
Very recently, Monuteaux, Biederman, Doyle, Mick, and Faraone (2009) reported no 
significant association between 5HTTLPR functional polymorphism of SLC6A4 and CD. 
Another gene, catechol O-methyltransferase gene (COMT) was examined by several groups, 
yielding contradictory results. Thapar et al. (2005) predicted that its homozygous genotype for 
valine allele, as well as its interaction with low birth weight, is associated with early-onset CD 
symptoms in ADHD children. Soon afterwards, nonsignificant results were reported by 
Sengupta et al. (2006). Recently, the positive results were obtained by Caspi et al. (2008) using 
three independent studies. However, Monuteaux et al. found no significant association between 
COMT Val/Met polymorphism and CD, although they specified that valine-valine 
homozygosity was associated with CD aggressive symptoms. 
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Genome-Wide Association Studies 
The conventional GWA study approach is a hypothesis-free, systematic search of tagging 
SNPs across the genome to identify novel associations with common diseases and has emerged 
as a powerful tool to identify disease-related genes for many common human disorders and 
other phenotypes (Guessous, Gwinn, & Khoury, 2009; McCarthy et al., 2008; Seng & Seng, 
2008; Wellcome Trust Case Control Consortium, 2007). 
Recently, the first hypothesis-free genome-wide association analysis of comorbid conduct 
problems in ADHD was performed by Anney et al. (2008), including CD. However, they did 
not find any of 1,043,963 autosomal markers that reached genome-wide significance 
(p<5×10-7), but 54 markers reaching strong genome-wide association signals (p<10-5), the top 
five of which were observed on chromosomes 13, 21, 11, 4, and 12.  
To sum, although a large number of linkage and association studies have focused on genetic 
influence on CD and made great achievements, certainty is lacked and further replication is 
required before specific loci are confirmed. 
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CHAPTER 3 
METHODS 
 
Datasets 
Collaborative Study on the Genetics of Alcoholism (COGA) Data and its Genetic Analysis 
Workshop 14 (GAW 14) Subset 
COGA is a nine-site national collaboration with the goal of identifying and characterizing 
genes that affect the vulnerability to alcoholism and related phenotypes (Edenberg et al., 2005). 
Besides alcohol dependence, the dataset contains the disease status for other behavioral 
problems, including CD, that were diagnosed by using the Semi-Structured Assessment for 
Genetics of Alcoholism (SSAGA) interview (Bucholz et al., 1994; Hesselbrock, Easton, 
Bucholz, Schuckit, & Hesselbrock, 1999). In total, 2,282 individuals from 262 families were 
available for genetic analyses. GAW 14 is a collaborative effort among genetic epidemiologists 
to evaluate and compare statistical genetic methods. A COGA data subset selected for GAW 14 
genotyping includes 1,353 individuals from 143 families and 11,560 SNP markers genotyped 
by Affymetrix GeneChip Mapping 10K Array and 4,752 SNPs from the Illumina’s Linkage Ш 
Panel (Edenberg et al., 2005). In order to reduce genetic heterogeneity, we selected 122 
Caucasian pedigrees (292 nuclear families with 1,335 individuals) that have a majority of 
individuals who self-reported to be 'white' (both Hispanic and non-Hispanic). Among the 1,335 
individuals, 670 are males and 665 are females. Their ages range from 7 to 93, with a mean of 
42 years old and standard deviation of 16.23. Affection status of CD is dichotomous. In our 
study, we defined 2 as affected, 1 as unaffected, and 0 as unknown. Totally, there are 155 
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individuals with a CD diagnosis, compared with 957 unaffected and 223 unknown. 
International Multi-Center ADHD Genetics Project (IMAGE) Dataset 
IMAGE is a project aiming at the detection of genes responsible for the genetic 
transmission of ADHD in children. The comorbidity of CD is examined in the during the 
assessment process. Anney et al. (2004) used this dataset to do the first hypothesis-free 
genome-wide analysis of CD in ADHD patients. We used part of this data to replicate our 
results for CD. In this study, 205 trios include 205 individuals with CD and their parents.  
 
Study Designs 
Family-based association studies, such as the transmission disequilibrium test (TDT), are 
preferable to case-control studies in allelic association studies when there is population 
admixture (Spielman, McGinnis, & Ewens, 1993). TDT detects preferential transmission of 
alleles from heterozygous parents to probands and is robust with respect to population 
stratification. Therefore, our study applied a genome-wide, family-based association analysis.  
 
Statistical Analysis 
 
Assessment of Hardy-Weinberg Equilibrium (HWE) 
Departure from HWE was tested for unaffected founders using PLINK (Purcell et al., 
2007). 
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Family-Based Association Analyses 
In this study, family-based association analysis for CD was performed by the P2BAT in R 
for autosomal SNPs because P2BAT can handle nuclear families as well as extended pedigrees 
(Hoffmann & Lange, 2006). To deal with X-chromosome SNPs the FBAT empirical variance 
(“-e”) option in FBAT was used to test for association because FBAT divides a large pedigree 
into small nuclear families and multiple sibs in a family are used (Rabinowitz & Laird, 2000). 
We also used part of IMAGE data to replicate our results in COGA data. For both two datasets, 
the additive model was applied. The family-based association test statistics in P2BAT/FBAT 
software are score tests that do not focus on the strength of association like odds ratio in the 
general case-control design. The primary aim of genetic association study is to search for the 
genetic influence of a disease, especially the location of genes affecting CD on the 
chromosome. We expect that our findings provide some evidence that the genetic component 
of CD may be probably located in specific loci.  
 
Multiple Testing 
For genome-wide statistical significance, we used conservative per-test significance level 
of α=5×10-7 for genome-wide statistical significance. Meanwhile, a moderate criterion of 
‘suggestive association’ with a cut-off α=10-3 was also applied. QVALUE was performed to 
determine the false discovery rate (FDR), which have been applied to microarray gene 
expression studies (Storey, 2002). 
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Fine-Mapping and Haplotype Analysis 
Linkage disequilibrium (LD) refers to the nonrandom association of alleles at adjacent 
loci. LD mapping, which involved searching association between a disease and alleles or 
haplotypes at mapped marker loci, has been proven a powerful tool for locating disease genes. 
LD is an association between the genotypes at two or more loci, typically observed as a disease 
phenotype and marker genotype(s) due to the close physical proximity of the loci, i.e. the 
disease susceptibility locus to one or more marker loci. When a disease mutation first occurs at 
a locus, it is on a specific member of two homologous chromosomes and therefore associated 
with all variants at loci close by on the same chromosome. 
Using HAPLOVIEW (Barrett, Fry, Maller, & Daly, 2005), we identified haplotype blocks 
(within a block, SNPs have strong LD each other) for interesting candidate genes or regions 
and chose several SNPs within blocks including the associated SNPs in the ADHD data. Using 
PBAT, we performed haplotyple analysis (using several flanking SNPs instead of single SNP) 
for SNPs within these candidate genes or regions. 
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CHAPTER 4 
RESULTS 
 
Assessment of Hardy-Weinberg Equilibrium (HWE) 
By testing HWE, we removed the SNPs with p<10-4 and those with minor allele frequency 
(MAF) < 0.01. Then, there were 11,120 SNPs left in the Affymetrix and 4,720 SNPs in the 
Illumina. 
 
Family-Based Association Analyses 
 
Genome-Wide Association Analysis in COGA Sample 
For COGA data, no SNPs reached genome-wide significance (p<5×10-7). There were 20 
SNPs have suggestive associations with CD (p<10-3) 9 of which are located in known genes 
(Table 1). All 183 SNPs which had a p-value of less than 0.01 are listed in Appendix B 
(Affymetrix) and Appendix C (Illumina). 
 
Table 1 
SNPs Associated with CD Based on HW p-value>10-4 and MAFa>0.01 Using HAPLOVIEW 
and p-value<10-3 Using P2BAT/FBAT for COGA Data 
Marker Chr Positionb (bp) Known Gene HWpval MAF P 
rs272411 19 59803539 LILRA1 0.2571 0.31199 0.0000316 
rs1380381 7 16780013 TSPAN13 0.3082 0.1643 0.0000457 
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Table 1 (continued) 
Marker Chr Positionb (bp) Known Gene HWpval MAF P 
rs1927724 13 98790313 UBAC2 0.4868 0.14873 0.0000467 
rs1568452 2 57866337 ---- 0.259 0.37202 0.0000545 
rs930983 11 122339624 ---- 0.3006 0.44052 0.0001426 
rs1116327 11 96909790 ---- 0.4242 0.44598 0.0002086 
rs1105009 9 102604800 ---- 1 0.03382 0.0002302 
rs383902 15 56821466 ADAM10 0.817 0.31413 0.0003606 
rs0725930 21 46014642 ---- 0.1165 0.10422 0.0006085 
rs1366121 5 158098565 EBF1 0.3497 0.19126 0.000611 
rs1986585 X 117393340 WDR44 0.0178 0.154 0.000627 
rs953111 1 219929051 ---- 0.4488 0.35885 0.0007562 
rs1883387 22 33536872 ---- 0.1128 0.28879 0.0007826 
rs2262391 4 167341423 ---- 0.1515 0.19516 0.000785 
rs903748 2 240817894 ---- 0.3013 0.17452 0.0008857 
rs805308 2 54048438 PSME4 0.212 0.47532 0.000915 
rs1381801 3 118723585 ---- 0.4017 0.38936 0.0009457 
rs2053053 5 149589586 CAMK2A 0.1941 0.37642 0.0009779 
rs720183 10 95141612 FER1L3 0.2851 0.14342 0.0009858 
rs59232 21 40137420 ---- 0.6174 0.3512 0.0009934 
a MAF refers to the minor allele frequency of the SNP. 
b Position is based on NCBI Genome Build 36.3. 
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Replication Study in IMAGE Sample 
Based on 20 SNPs with p <10-3 in the COGA sample, we selected 332 SNPs from IMAGE 
dataset in order to replicate our results for CD. For the SNPs in COGA data within candidate 
genes, we chose all the SNPs within those genes while for each SNP in COGA data that are not 
located in known gene, we chose two flanking SNPs in the IMAGE dataset. In addition, 
candidate genes identified by Anney et al. (2008) that showed significant association at the 
level of α=0.01 in our study were also be included. Fourteen of the 332 SNPs were in HWE 
(p>10-4) with MAF>0.01 and significantly (p<0.05) associated with CD (Table 2). Among 
these SNPs, the most significant one was rs4774309 on chromosome 15 (p=0.0016), which is 
located in the gene ADAM10. 
 
Table 2 
SNPs Associated with CD Based on HW p-value>10-4 and MAFa>0.01 Using HAPLOVIEW 
and p-value<0.05 Using PBAT for IMAGE Sample 
Marker Chr Positionb Known Gene HWpval MAF Nc P 
rs4774309 15 56722756 ADAM10 0.001 0.198 101 0.0016 
rs789560 12 68618094 C12orf28 0.815 0.13 90 0.003264 
rs1152969 12 68599549 C12orf28 0.6436 0.036 24 0.004267 
rs11187400 10 95119911 FER1L3 1 0.014 8 0.004678 
rs1345610 5 158149617 EBF1 0.12 0.041 27 0.005346 
rs11747044 5 158296035 EBF1 1 0.028 24 0.009322 
rs1152962 12 68608074 C12orf28 0.9855 0.379 148 0.015258 
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Table 2 (continued) 
Marker Chr Positionb Known Gene HWpval MAF Nc P 
rs1560044 5 158067098 EBF1 0.8821 0.344 144 0.015813 
rs2241694 5 149582801 CAMK2A 0.125 0.082 67 0.018422 
rs1240251 12 68510959 C12orf28 0.0042 0.152 88 0.024745 
rs1674563 12 68529636 C12orf28 0.2378 0.499 158 0.032008 
rs17056162 5 158109647 EBF1 0.8942 0.1 66 0.033895 
rs919740 5 149646042 CAMK2A 0.0417 0.248 118 0.037881 
rs10417589 19 59798475 LILRA1 1 0.1 67 0.046624 
a MAF refers to the minor allele frequency of the SNP. 
b Position is based on NCBI Genome Build 36.3. 
c N refers to the number of informative families.  
 
Multiple Testing 
Based on the 10,808 p-values for associations with CD in the Affymetrix SNP panel in the 
COGA sample, the FDR was calculated to handle multiple comparisons. In terms of the 
q-value, when the p-value cutoff was set to be 0.001, we would expect 59.9% false positive 
results (FDR=0.599). If the p-value cutoff was set to be 0.0001, we would expect 15.6% false 
positive results (FDR=0.156).  
 
Fine-Mapping and Haplotype Analysis 
We chose SNPs that were in HWE (p>10-4) with MAF>0.01 within ADAM10 and 
CAMK2A from IMAGE sample to do fine-mapping. Among 17 SNPs in ADAM10, 13 of them 
were in five blocks and showed strong linkage disequilibrium (LD) (Figure 1).   
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Figure 1. Pairwise LD between 17 SNPs within ADAM10, given by the D'. 
 
Among 24 SNPs in CAMK2A, 6 of them were in two blocks with strong LD (Figure 2 and 
Figure 3). 
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Figure 2. Pairwise LD between first 12 SNPs within CAMK2A, given by the D'. 
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Figure 3. Pairwise LD between the rest 12 SNPs within CAMK2A, given by the D'. 
 
We did haplotype analysis for each 2 adjacent SNPs of all 332 SNPs in IMAGE data. 
Within ADAM10 and CAMK2A, there were 9 and 4 haplotypes significantly (p<0.05) 
associated with CD, respectively (Table 3). 
 
Table 3 
Haplotypes Associated with CD Based on p-value<0.05 Using PBAT for IMAGE Sample 
Gene SNPs Haplotype Hapfreqa Nb p 
ADAM10 rs4774309-rs2114573 G-T 0.08608 51 0.00000158 
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Table 3 (continued) 
Gene SNPs Haplotype Hapfreqa Nb P 
 
rs12900643-rs4774309 T-G 0.08072 54 0.0000232 
ADAM10 
rs4774309-rs2114573 C-T 0.7832 93 0.000389248 
rs12900643-rs4774309 T-C 0.60795 132 0.001386355 
rs16940587-rs16940589 T-C 0.01226 11 0.014305878 
rs8027998-rs347117 G-C 0.02812 19 0.027223353 
rs8033691-rs2054096 T-T 0.15989 88 0.039222871 
rs1427282-rs8043406 A-G 0.06073 42 0.043205003 
rs8043406-rs12899638 A-G 0.05504 38 0.046393843 
CAMK2A 
rs10068882-rs919740 T-G 0.14629 78 0.00864467 
rs2241694-rs4958469 A-G 0.07962 67 0.024024611 
rs17656349-rs6885505 C-T 0.12141 72 0.03218256 
rs919740-rs873592 T-C 0.24418 116 0.04211522 
a Hapfreq refers to the frequency of the haplotype. 
b N refers to the number of informative families.  
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CHAPTER 5 
DISCUSSION 
 
By conducting family-based association studies, we replicated some of the results of 
previous studies and found some novel genetic variants of CD. 
For COGA data, the most significant SNP from Affymetrix is rs272411 on chromosome 19 
(p=0.0000316), and the most significant SNP from Illumina is rs1568452 on chromosome 2 
(p=0.0000545), which are just the 2 chromosomes that were reported the highest risk to CD by 
Dick et al. (2004). SNP rs272411 is located in LILRA1 but no association of this gene with any 
psychiatric or neurological disorder was reported so far.  
Compared with the results of the study conducted by Anney et al. (2008), only one 
candidate gene (C12orf28, rs789560 with p=0.0000072) is supported by our analysis of COGA 
data. rs0720367 from Affymetrix and rs1240267 from Illumina are both located in C12orf28, 
with p=0.00246849 and 0.002924242, respectively. However, this gene is well supported by 
our replication using IMAGE data, in which 5 SNPs reached the statistical significance 
(p<0.05). C12orf28 is an open reading frame on chromosome 12. But the function is still 
unknown. 
Among all SNPs that had a p-value of less than 0.001, 9 are located on known genes. 
Unfortunately, none of them has been proved associated with CD. However, 2 genes attracted 
our attention. ADAM10 on chromosome 15 (rs383902 with p=0.000360549) is a member of 
ADAM family that encodes cell surface proteins with a unique structure possessing both 
potential adhesion and protease domains. ADAM10 has been proved as an important role in 
30 
 
amyloid precursor protein proteolysis, which is a key event in the pathogenesis of Alzheimer's 
disease (AD). Colciaghi et al. (2002) reported a reduced level of ADAM10 in AD patients’ 
platelets. Contradictorily, Gatta, Albertini, Ravid, and Finazzi (2002) reported a two-fold 
higher of ADAM10 mRNA levels in AD patients than controls. The identification of possible 
association of ADAM10 with CD may lead to further study of the relationship among ADAM10, 
CD, and AD. 
CAMK2A on chromosome 5 (rs2053053 with p=0.000977901) encodes the alpha subunit 
of Calcium/calmodulin-dependent protein kinase II, which is a ubiquitous serine/threonine 
protein kinase that is abundant in the brain as a major constituent of the postsynaptic density. 
Altered expression of CAMK2A has been reported associated with bipolar disorder and 
depression. For example, there is a significant decrease in CAMK2A mRNA in bipolar disorder 
patients (Xing et al., 2002) and a 29% increase in depression patients (Novak, Seeman, & 
Tallerico, 2006). In order to find out whether there is shared pathogenesis of CD, bipolar 
disorder, and depression more studies are needed. Although there is no report of association of 
CAMK2A with CD in humans, an animal model has been established. Chen, Rainnie, Greene, 
and Tonegawa (1994) observed a decreased fear response and an increased aggressive behavior 
in heterozygous mutant mice deficient for CAMK2A that provided some evidence for CAMK2A 
effect on the human psychiatric diseases involving increased risk-taking behaviors, including 
CD. 
Using part of IMAGE data, we replicated our results for most known genes identified in 
COGA data, including ADAM10 (rs4774309 with p=0.0016) and CAMK2A (rs2241694 with 
p=0.018422, rs919740 with p=0.037881). When doing two-marker haplotype analysis instead 
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of single SNP analysis, we found that within gene ADAM10, the 4 most significant haplotypes 
all include SNP rs4774309, which had been identified most significantly associated with CD 
using in IMAGE sample. Meanwhile, the 2 most significant haplotypes within gene CAMK2A 
just contain 2 SNPs rs919740 and rs2241694 that each showed significant association with CD 
in our previous single marker analysis. These results provide further evidence that ADAM10 
and CAMK2A have association with CD. 
Besides the above-discussed 2 genes, there are still other genes that have been replicated by 
our analysis of IMAGE sample. For example, 4 SNPs were in the gene EBF1 (early B-cell 
factor 1) on chromosome 5. This gene has been proved one of the genes that are subject to 
random monoallelic expression (Gimelbrant, Hutchinson, Thompson, & Chess, 2007). But no 
psycho-disorders have been reported to be associated with this gene so far. 
In our analysis of COGA data, 3 other genes that contain SNPs associated with CD at the 
level of α=0.01 are of interest to us. ROBO2 on chromosome 3 (rs876675 with p=0.001593182) 
encodes a receptor for SLIT2, which functions in axon guidance and cell migration. Besides 
vesicoureteral reflux type 2, defects in this gene may lead to autism (Anitha et al., 2008) and 
schizophrenia (Potkin et al., 2009). But the results require confirmation in independent 
samples. 
NTRK2 on chromosome 9 (rs1778970 with p=0.002368143 and rs1838158 with 
p=0.007260911) encodes the receptor for brain-derived neurotrophic factor. Mutations in this 
gene are associated with mood disorders, including nicotine dependence (Beuten et al., 2007; 
Vink et al., 2009), alcohol dependence (Xu et al., 2007), obsessive-compulsive disorder 
(Alonso et al., 2008), Alzheimer's disease (Chen et al., 2008; Cozza et al., 2008), and bipolar 
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disorder (Smith et al., 2009). Because the data we used were collected initially for alcohol 
dependence, the association of this gene with CD may due to confounding. 
MME on chromosome 3 (rs1025192 with p=0.007969908) encodes a common acute 
lymphocytic leukemia antigen that is an important cell surface marker in the diagnosis of 
human acute lymphocytic leukemia. However, this protein is not restricted to leukemic cells 
and can be found in many normal tissues. Neurologists have focused on the relationship 
between this gene and Alzheimer's disease, but the results were inconsistent. Positive results 
have been reported in Finnish (Helisalmi et al., 2004) and Chinese sample (Shi et al., 2005), 
while no association was observed in Japanese (Oda et al., 2002), Swedish (Lilius et al., 2003), 
and a south Chinese population (Fu et al., 2009). 
By comparing our study with existed studies, we found some similarities and dissimilarities. 
First, our results provide support to the findings of Dick et al. (2004) in a linkage analysis. We 
discovered that the associations of SNPs provided by Affymetrix and Illumina are most 
significant on chromosome 19 and chromosome 2, respectively, while Dick et al. suggested 
regions on these two chromosomes confer highest risk of CD. Second, we performed a 
family-based, genome-wide association analysis, which were the same design as what Anney 
et al. (2008) did. However, we used different sample, with the focus on the identification of 
novel genetic variants, not only using a more powerful family-based method in P2BAT, but 
also dealing with X-chromosome SNPs. In addition, to reduce the genetic heterogeneity, we 
just used 122 Caucasian pedigrees (292 nuclear families) which have a majority of individuals 
who self-reported to be 'White' (both Hispanic and non-Hispanic). In our analysis, we found 
neither significant genome-wide association (p<5×10-7) nor strong genome-wide association 
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(p<10-5) of SNPs with CD, probably due to much less amount of SNPs we used (16,312 SNPs), 
thus limiting the coverage of the genome. Although using a much less stringent criterion 
(α=0.01), only one candidate gene C12orf28 identified by Anney et al. (2008) is supported by 
our analysis. However, we found 2 novel, suggestive genes, ADAM10 and CAMK2A, which 
was not reported by them or other previous studies. These 2 candidate genes were also proved 
by replicating family-based analysis and haplotype analysis using part of IMAGE sample. 
From a public health point of view, potential application of genetic association studies 
includes that if specific genes are further confirmed, screening for these genes may be possible 
in newborns and other populations to detect people of high risk before the disease occurs. 
Because within each genetic variant that is associated with one complex disease like CD, the 
allele with relatively higher risk is known, newborn and population screening of these specific 
loci may differentiate those with high risk alleles from those with low risk alleles, thus 
narrowing down the range of population who need further follow up and intervention. 
One important goal of genetic epidemiology study is to look at gene-environment 
interaction affecting complex diseases like CD after the main effects of genes have been 
detected. The present study focused on the identification of the associated genes with CD. 
However, several studies have shown that environmental factors and their interactions with 
genetic variants contribute to CD. For example, Caspi et al. (2002) reported an interaction 
between the level of MAOA expression and maltreatment of white male children, suggesting 
that high levels of MAOA may moderate the effect of maltreatment on the development of 
antisocial behavior. Later, Foley et al. (2004) replicated his findings in white male CD patients 
that genotypes associated with low MAOA increased risk for CD only in the presence of 
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adverse child environment. Recently, Widom and Brzustowicz (2006) extended their 
discoveries to show that the MAOA gene interacted with child abuse and neglect in both white 
boys and girls on the development of violent and antisocial behavior. Other environmental 
factors were also tested. Braun et al. (2008) examined the association of tobacco smoke and 
environmental lead exposure with CD, suggesting that prenatal tobacco exposure and 
environmental lead exposure contribute substantially to CD in U.S. children. Very recently, 
Hay, Pawlby, Waters, Perra, and Sharp (2010) reported that mothers' depression in pregnancy 
placed their children at a twofold risk for antisocial outcomes, and at a fourfold risk for violent 
behavior, indicating that mothers' antenatal depression as a predictor of their children's 
antisocial outcomes. These studies provided sufficient evidence that in searching for the 
pathogenesis of CD, environmental factors cannot be neglected.  
Several limitations of our study merit comment. First, just as Dick et al. (2004) mentioned, 
the COGA sample was selected through alcoholic probands. In order to yield more accurate 
support of gene loci contributing to CD, a sample particularly collected for the purpose of CD 
is needed. Second, the sample size is relatively small and the two SNP panels have limited 
coverage of the genome. These cause the inability to detect weak to moderate genetic effect 
(Dick et al., 2004). Third, the genes detected in our study only reached suggestive evidence of 
association, which need to be replicated in independent samples.  
In spite of the above limitations, the present study has several strengths. First, rather than 
candidate gene studies, which select genes for study based on known or suspected disease 
mechanisms, we performed GWA studies. By scanning the whole genome, GWA studies have 
the potential to identify totally novel loci for CD. Second, we used a family-based design 
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instead of a population based case-control design. This reduces the type 1 error arising from 
population stratification. Third, by limiting analyses to Caucasian pedigrees, we minimized 
risk of type 1 error due to genetic heterogeneity. 
In summary, this study identified several CD associated genetic variants, especially two 
genes, ADAM10 and CAMK2A that have been shown in previous studies to affect several other 
psychiatric or neurological diseases such as Alzheimer's disease, bipolar disorder, and 
depression. These findings may serve as a resource for replication in other populations and 
provide a foundation for future investigations. Future studies are warranted to verify the 
strength of association between the genetic factors and CD and gene-environment interaction 
on the development of CD. 
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APPENDIXES 
 
Appendix A. Glossary 
Term Definition 
Allele 
Either of a pair (or series) of alternative forms of a gene that can 
occupy the same locus on a particular chromosome and that control 
the same character (Miller, 1995). 
Single Nucleotide 
Polymorphism (SNP) 
Genetic variation in a DNA sequence that occurs when a single 
nucleotide in a genome is altered (Miller, 1995). 
Genome-wide 
Association Study 
(GWAS) 
Test of the association between markers across the genome and 
disease (Hardy and Singleton, 2009). 
Transmission 
Disequilibrium Test 
(TDT) 
A family-based association test which considers parents who are 
heterozygous for an allele associated with disease and evaluates the 
frequency with which that allele or its alternate is transmitted to 
affected offspring (Spielman et al., 1993). 
Hardy-Weinberg 
Equilibrium (HWE) 
The state of the genotypic frequency of two alleles of one autosomal 
gene locus after one discrete generation of random mating in an 
indefinitely large population (Mayo, 2008). 
Haplotype 
A combination of alleles that are located closely together on the 
same chromosome and that tend to be inherited together (Miller, 
1995). 
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Appendix B. SNPs Associated with CD Based on the p-value for P2BAT/FBAT (p<0.01) in 
COGA Data (Affymetrix) 
Chr Marker Position Known Gene HWpval MAF P 
1 rs0953111 219929051 ---- 0.4488 0.359 0.0007562 
1 rs1343817 111238652 CD53 0.5367 0.471 0.00108088 
1 rs1926256 69651662 ---- 1 0.154 0.00417073 
1 rs1441834 29945688 ---- 0.02237 0.237 0.00438844 
1 rs0826415 117955500 FAM46C 0.8498 0.298 0.00515691 
1 rs2095785 99971477 FRRS1 0.3636 0.122 0.00568108 
1 rs1415260 160351771 NOS1AP 0.1799 0.442 0.00912208 
2 rs1406418 51609235 ---- 1 0.015 0.00109905 
2 rs2013708 71453862 ZNF638 0.08115 0.117 0.0012599 
2 rs0956099 53516816 ---- 0.7489 0.459 0.00130159 
2 rs1530272 88196333 ---- 0.5928 0.388 0.00193553 
2 rs2139053 58010043 ---- 0.7418 0.377 0.00274309 
2 rs0951431 117865700 ---- 0.4791 0.223 0.00403683 
2 rs1516238 117865378 ---- 0.4791 0.223 0.00403683 
2 rs0720796 40035896 LOC100128590 0.03377 0.464 0.00425925 
2 rs1399959 172140552 ---- 0.0512 0.302 0.00463357 
2 rs2078542 148122694 ---- 0.8616 0.351 0.00471943 
2 rs1907544 116966960 ---- 0.8227 0.315 0.00585939 
2 rs1448836 168224982 ---- 0.8391 0.267 0.00597448 
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Appendix B (continued) 
Chr Marker Position Known Gene HWpval MAF P 
2 rs1376586 199759635 ---- 0.8681 0.459 0.00622715 
3 rs1381801 118723585 ---- 0.4017 0.389 0.00094571 
3 rs0952384 116387931 ---- 0.5991 0.112 0.00137034 
3 rs0721779 60604879 ---- 1 0.199 0.00220199 
3 rs1398922 18645164 ---- 0.03858 0.344 0.00391375 
3 rs1554560 154857857 ---- 0.3955 0.49 0.00530724 
3 rs2083948 106828663 ---- 1 0.145 0.00581919 
3 rs1401965 152942197 AADACL2 0.241 0.26 0.00691127 
3 rs0768324 85222091 ---- 0.3791 0.075 0.00840476 
3 rs1395166 31153785 ---- 0.3822 0.175 0.00864825 
3 rs0951015 24028796 ---- 0.4924 0.337 0.008885 
4 rs2262391 167341423 ---- 0.1515 0.195 0.000785 
4 rs1373475 36607819 ---- 0.4687 0.16 0.00204416 
4 rs0952938 63436594 ---- 0.4204 0.458 0.0022952 
4 rs0725001 125407498 ---- 0.07951 0.465 0.00458047 
4 rs4133280 130406957 ---- 1 0.122 0.00537809 
4 rs1822528 99890067 ---- 0.6192 0.269 0.00658844 
4 rs0939353 25204915 ---- 0.2713 0.241 0.00685781 
4 rs1373053 32879410 ---- 1 0.028 0.00691539 
4 rs1443786 83129627 ---- 1 0.286 0.00809744 
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Appendix B (continued) 
Chr Marker Position Known Gene HWpval MAF P 
4 rs1357032 28572026 ---- 0.5061 0.408 0.00843092 
5 rs1366121 158098565 EBF1 0.3497 0.191 0.00061095 
5 rs0032524 13282435 ---- 1 0.182 0.00284293 
5 rs701380 79812643 ---- 1 0.065 0.00487153 
5 rs0724865 73826179 ---- 1 0.113 0.00539712 
5 rs1914212 160313280 ---- 0.1444 0.234 0.00546864 
5 rs0324066 40952422 C7 0.7306 0.407 0.00621991 
5 rs0723852 57466589 ---- 0.3114 0.071 0.00876685 
6 rs0721101 155674536 TFB1M 0.653 0.269 0.00100394 
6 rs1409098 53990299 C6orf142 0.4152 0.421 0.00434218 
6 rs0950995 155662744 TFB1M 0.7815 0.158 0.00670292 
6 rs2327212 132920951 ---- 1 0.149 0.00724124 
6 rs0951318 1263711 ---- 1 0.14 0.00751216 
7 rs1380381 16780013 TSPAN13 0.3082 0.164 0.0000457 
7 rs1443753 121736554 ---- 0.5364 0.323 0.0013715 
7 rs0719340 133997674 BPGM 0.2909 0.394 0.00251761 
7 rs0727430 8823441 ---- 0.04496 0.378 0.00371915 
7 rs2392383 35760695 ---- 0.8657 0.413 0.00404995 
8 rs1396977 131791884 ---- 0.871 0.431 0.0015906 
8 rs0344288 63029421 ---- 0.7424 0.465 0.00207002 
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Appendix B (continued) 
Chr Marker Position Known Gene HWpval MAF P 
8 rs2137636 114551461 ---- 0.7358 0.208 0.00242161 
8 rs0344285 63029703 ---- 0.2564 0.338 0.00259531 
8 rs2203657 63034569 ---- 0.8681 0.465 0.00265834 
8 rs0684872 63034323 ---- 0.8686 0.465 0.00316347 
8 rs1381665 76930139 ---- 1 0.267 0.00350421 
8 rs0958374 9235071 ---- 0.7507 0.496 0.00588367 
8 rs1491467 127032094 LOC100130231 1 0.049 0.00596978 
8 rs0344286 63029664 ---- 0.6913 0.33 0.00955546 
9 rs1105009 102604800 ---- 1 0.034 0.00023016 
9 rs1856203 113532633 C9orf84 1 0.218 0.00178912 
9 rs2383292 23783644 ELAVL2 1 0.01 0.00419286 
9 rs1838158 86662829 NTRK2 0.3026 0.137 0.00726091 
9 rs1419253 19882748 ---- 0.04635 0.361 0.00802226 
9 rs0439269 14481347 ---- 0.7406 0.124 0.00827884 
9 rs3914504 30738943 ---- 0.4116 0.199 0.00918118 
9 rs0063319 74714604 ALDH1A1 1 0.446 0.00936777 
10 rs0720183 95141612 FER1L3 0.2851 0.143 0.00098577 
10 rs1408342 102638742 ---- 0.6776 0.109 0.00231688 
10 rs0829108 95395414 PDE6C 0.6362 0.231 0.00494065 
10 rs0958852 61992624 ---- 0.565 0.253 0.00587419 
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Appendix B (continued) 
Chr Marker Position Known Gene HWpval MAF P 
10 rs0952965 108187118 ---- 0.009377 0.441 0.00743779 
10 rs0604489 95395398 PDE6C 0.8256 0.235 0.00853557 
10 rs0723009 61992601 ---- 0.699 0.261 0.00983909 
11 rs1116327 96909790 ---- 0.4242 0.446 0.00020861 
11 rs2097160 96909766 ---- 0.1328 0.401 0.00134155 
11 rs0724202 26532254 TMEM16C 0.05779 0.295 0.00180448 
11 rs1939546 59505456 LOC255649 0.6697 0.241 0.00397862 
11 rs2170655 18977997 ---- 0.8739 0.496 0.00622446 
11 rs1391610 5384031 ---- 0.8254 0.416 0.00664355 
11 rs0951933 78800124 ---- 0.3451 0.189 0.0091399 
11 rs1404501 63041086 LGALS12 0.2651 0.244 0.00948556 
12 rs1369035 81928655 TMTC2 0.1703 0.14 0.00162996 
12 rs0710741 68315603 ---- 0.4566 0.222 0.00174063 
12 rs0720367 68568050 C12orf28 0.3065 0.217 0.00246849 
12 rs2029692 65279429 GRIP1 0.5088 0.154 0.0031165 
12 rs1295815 74494077 ---- 0.2284 0.225 0.00375672 
12 rs0726603 44378810 ---- 0.6046 0.38 0.00608295 
12 rs0035426 114054429 ---- 0.06322 0.392 0.00995411 
13 rs1927724 98790313 UBAC2 0.4868 0.149 0.0000467 
13 rs2149144 105246932 ---- 0.2132 0.11 0.00326126 
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Appendix B (continued) 
Chr Marker Position Known Gene HWpval MAF P 
13 rs1998676 32884219 ---- 1 0.022 0.00815097 
14 rs1950702 32110983 AKAP6 0.6571 0.258 0.00306025 
14 rs1959619 19490525 ---- 1 0.325 0.00546271 
14 rs1074925 94931266 ---- 0.5279 0.166 0.00693578 
14 rs1959482 70197453 TTC9 0.499 0.26 0.00733144 
15 rs0717552 84884126 AGBL1 0.145 0.454 0.00782124 
16 rs2363306 88696275 LOC728262 1 0.068 0.00471772 
17 rs0953113 22839015 KSR1 0.4206 0.446 0.00696989 
17 rs1807333 895321 ABR 0.3146 0.327 0.00937469 
18 rs0959655 48132862 DCC 1 0.159 0.00195585 
18 rs1073006 1870289 ---- 0.4678 0.131 0.00238622 
19 rs0272411 59803539 LILRA1 0.2571 0.312 0.0000316 
19 rs3810261 54914726 ---- 0.346 0.135 0.00874232 
20 rs0727662 50708872 ---- 0.182 0.403 0.00235992 
20 rs0715433 50712238 ---- 0.1013 0.37 0.00315178 
20 rs2208970 12325493 ---- 1 0.336 0.00947568 
21 rs0725930 46014642 ---- 0.1165 0.104 0.00060846 
21 rs0059232 40137420 ---- 0.6174 0.351 0.00099339 
21 rs0966179 18808558 ---- 0.004548 0.166 0.00505555 
21 rs0978422 18764448 ---- 0.3715 0.492 0.00595544 
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Appendix B (continued) 
Chr Marker Position Known Gene HWpval MAF P 
21 rs2226672 24923099 ---- 0.8696 0.488 0.00652364 
21 rs1543289 41157388 ---- 0.05416 0.33 0.00711574 
21 rs0724208 33413854 ---- 1 0.442 0.00846215 
22 rs1883387 33536872 ---- 0.1128 0.289 0.00078255 
X rs1986585 117393340 WDR44 0.01778 0.154 0.000627 
X rs1949393 86436628 ---- 0.226 0.234 0.001073 
X rs0724533 116542720 ---- 0.562 0.189 0.001435 
X rs0724534 116542916 ---- 0.2022 0.159 0.002122 
X rs2034391 27198082 ---- 0.4493 0.363 0.003838 
X rs0742997 142509623 ---- 0.7614 0.378 0.004138 
X rs2179329 112201908 ---- 0.8253 0.427 0.005618 
X rs2012646 100945756 ---- 0.3087 0.492 0.007706 
X rs2366517 136887785 ---- 1 0.378 0.008602 
X rs0724270 32244571 DMD 0.7964 0.311 0.008977 
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Appendix C. SNPs Associated with CD Based on the p-value for P2BAT/FBAT (p<0.01) in 
COGA Data (Illumina) 
Chr Marker Position Known Gene HWpval MAF P 
1 rs636101 120058236 PHGDH 0.03237 0.28416 0.004198982 
1 rs1557061 56520770 ---- 0.522 0.40385 0.008725978 
1 rs736861 40703590 ---- 0.6505 0.39006 0.009273092 
1 rs1464816 202395477 REN 0.6103 0.31091 0.009465632 
2 rs1568452 57866337 ---- 0.259 0.37202 0.0000545 
2 rs903748 240817894 ---- 0.3013 0.17452 0.000885744 
2 rs805308 54048438 PSME4 0.212 0.47532 0.000914964 
2 rs805423 53980545 PSME4 0.2984 0.47905 0.001253577 
2 rs925229 24087944 LOC388931 1 0.47017 0.008256606 
2 rs1446596 209993773 ---- 0.8342 0.47872 0.008381974 
3 rs876675 77758328 ROBO2 0.6801 0.48616 0.001593182 
3 rs531577 139883989 PIK3CB 0.6136 0.30425 0.003338441 
3 rs13975 126284921 SLC12A8 0.2022 0.46283 0.004634245 
3 rs1997422 125463298 KALRN 0.6767 0.45092 0.005899007 
3 rs4796 32498781 CMTM6 0.6726 0.48239 0.006523697 
3 rs877439 169282596 GOLIM4 0.5378 0.49688 0.007811044 
3 rs1025192 156310481 MME 0.1519 0.37947 0.007969908 
3 rs2061719 81336030 ---- 0.02178 0.34904 0.008160368 
3 rs1995137 42106419 TRAK1 0.301 0.46211 0.009773593 
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Appendix C (continued) 
Chr Marker Position Known Gene HWpval MAF P 
4 rs1968778 21427412 KCNIP4 1 0.48212 0.004552297 
4 rs1879462 63476530 ---- 0.5352 0.46425 0.007950792 
5 rs2053053 149589586 CAMK2A 0.1941 0.37642 0.000977901 
5 rs887346 149576185 ---- 0.1217 0.3821 0.002868128 
5 rs949602 157323418 ---- 0.1339 0.45307 0.007729952 
5 rs726847 136100004 ---- 0.7963 0.28807 0.007938675 
5 rs1501656 81822452 ---- 0.1795 0.35881 0.008460381 
6 rs13161 26222681 ---- 0.06232 0.18871 0.003444944 
6 rs612928 144640677 ---- 1 0.41398 0.007091924 
8 rs344278 63031658 ---- 0.5282 0.4642 0.003427216 
9 rs1778970 86585630 NTRK2 0.8274 0.35805 0.002368143 
9 rs952765 99407127 C9orf97 0.484 0.32155 0.003307284 
9 rs1336980 128417676 LMX1B 0.3635 0.34885 0.008979658 
10 rs1887984 110103015 ---- 0.325 0.35812 0.007722015 
11 rs930983 122339624 ---- 0.3006 0.44052 0.000142593 
11 rs160195 87932621 GRM5 0.1342 0.40028 0.009626499 
12 rs1542707 46921444 ---- 0.4137 0.22557 0.0016836 
12 rs1240267 68570395 C12orf28 1 0.23551 0.002924242 
13 rs735600 67900291 ---- 0.522 0.38254 0.008109404 
13 rs1856277 108249564 MYO16 0.2877 0.39524 0.008370048 
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Appendix C (continued) 
Chr Marker Position Known Gene HWpval MAF P 
14 rs221924 70650531 PCNX 0.591 0.12117 0.002664231 
15 rs383902 56821466 ADAM10 0.817 0.31413 0.000360549 
15 rs347117 56788249 ADAM10 0.809 0.32123 0.002375717 
15 rs610877 56890620 FAM63B 1 0.32491 0.003242261 
15 rs395601 56850488 FAM63B 0.2645 0.33428 0.004928419 
15 rs387812 56862078 FAM63B 0.517 0.40267 0.008158609 
17 rs1043127 59144942 LYK5 0.4007 0.47327 0.006026961 
17 rs727999 24570756 ---- 0.07223 0.19052 0.008685683 
19 rs36633 59338102 CNOT3 0.6801 0.43693 0.004842536 
21 rs2210267 40685095 DSCAM 0.5336 0.43914 0.003792539 
X rs2064034 48708920 KCND1 1 0.459 0.001652 
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